Physician profile
George Converse
NPI 1447298476
$3,021.74
in general payments reported to CMS, 2019-2025
17 companies · $924 in 2025
The $924 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $145 · 2021: $479 · 2022: $286 · 2023: $315 · 2024: $612 · 2025: $924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,277.79 | 2019-2025 | Xpress Ent Dilation System, Scopis Ent, Audion Et Dilation System |
| Aerin Medical INC. | $463.54 | 2024-2025 | |
| Inspire Medical Systems, INC. | $423.54 | 2024-2025 | Inspire |
| Genzyme Corporation | $228.96 | 2024-2025 | |
| Optinose US, INC. | $148.44 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $141.56 | 2022-2025 | Dupixent, Libtayo |
| Glaxosmithkline, LLC. | $130.49 | 2022-2024 | Nucala |
| Smith+Nephew, INC. | $35.05 | 2023 | Halo |
| Olympus America INC. | $27.43 | 2020 | |
| Integra Lifesciences Corporation | $23.63 | 2019 | |
| Genentech USA, INC. | $22.60 | 2022 | |
| Neurent Medical Limited | $22.04 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Alk-Abello, INC | $20.08 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.35 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.40 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $13.08 | 2024 | Ryaltris |
| Intersect Ent, INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Converse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.